Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
Sales per Business
USD in Million | 2002 | Weight | 2003 | Weight | Delta |
---|---|---|---|---|---|
Joint Development Agreement Revenue
nan
%
| 3 | 100.0 % | 0 | nan % | -100.00% |
Sales per region
USD in Million | 2002 | Weight | 2003 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 3 | 100.0 % | 0 | nan % | -100.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ian Morrice
DFI | Director of Finance/CFO | - | - |
President | 68 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | - | |
Ian Morrice
DFI | Director of Finance/CFO | - | - |
Company contact information
Spencer Pharmaceutical, Inc.
8 Faneuil Hall Marketplace 3rd floor
02109, Boston
+
![address Spencer Pharmaceutical Inc.(SPPH)](https://cdn.zonebourse.com/static/address/120792711.png)
Sector
- Stock Market
- Equities
- SPPH Stock
- Company Spencer Pharmaceutical Inc.